Gyre Therapeutics (GYRE) Total Debt (2010 - 2016)

Gyre Therapeutics (GYRE) has 7 years of Total Debt data on file, last reported at $28000.0 in Q3 2016.

• Total Debt for Q3 2016 came in at $28000.0, down 95.86% year-over-year; the trailing twelve-month figure through Sep 2016 was $28000.0 (down 95.86% YoY), and the FY2015 annual result was $1.2 million, changed N/A from the prior year.
• Total Debt retreated to $28000.0 in Q3 2016 per GYRE's latest filing, from $130000.0 in the prior quarter.
• Over five years, Total Debt peaked at $2.7 million in Q1 2012 and troughed at $28000.0 in Q3 2016.
• A 5-year average of $1.2 million and a median of $1.1 million in 2013 frame the typical range for Total Debt.
• The sharpest annual moves came in 2015 and 2016: Total Debt jumped 41.42% in 2015, then sank 95.86% in 2016.
• A 5-year view of Total Debt shows it stood at $2.0 million in 2012, then tumbled by 42.83% to $1.1 million in 2013, then plunged by 57.92% to $478000.0 in 2014, then soared by 141.84% to $1.2 million in 2015, then slumped by 97.58% to $28000.0 in 2016.
• Business Quant data shows GYRE's Total Debt at $28000.0 in Q3 2016, $130000.0 in Q2 2016, and $196000.0 in Q1 2016.